Learn More
Medchemexpress LLC Abequolixron (hydrochloride) | 610318-54-2 | 99.9% | 596.08 g·mol⁻¹ | C34H33ClF3NO3 | 5 MG

Supplier: Medchemexpress LLC HY111498A5MG
RGX-104 (abequolixron) is an orally bioavailable small-molecule liver X receptor (LXR) agonist used in preclinical and research settings to modulate innate immunity through transcriptional activation of the ApoE gene. Supplied as a characterized research-grade solid, it is suitable for assay development and pharmacological evaluation in vitro and in vivo.
- Orally bioavailable LXR agonist suitable for pharmacology studies.
- Modulates innate immunity via ApoE transcriptional activation.
- Provided as characterized research-grade solid for assay development.
- Analytical data available, including molecular formula, molecular weight, and purity.
- Compatible with in vitro and in vivo experimental models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.